Archive | December, 2018

PPMI Study Enters a New Phase

by Krishna Knabe The Michael J. Fox Foundation The Parkinson’s Progression Markers Initiative (PPMI) has reached an important milestone: the study completed enrollment. We have now met the ambitious goal we set back in 2010 of enrolling 1,400 participants, including 600 with rare genetic mutations. PPMI is The Michael J. Fox Foundation’s landmark observational clinical […]

Continue reading...

PPMI Data Available: RNA Seq

by Bradford Casey, Ph.D. The Michael J. Fox Foundation The Parkinson’s Progression Markers Initiative (PPMI) includes a broad and comprehensive panel of measurements designed to improve our understanding of Parkinson’s disease (PD). One approach is analysis of the genome, the full complement of DNA present within the cells of the body. DNA is often considered […]

Continue reading...